David Schleinkofer, MD
Clinical Cardiac Electrophysiology · Fort Wayne, INNPI 1326030297
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $12,390 of the $19,300 with a category attached, or 64.2%. 19 manufacturers reported payments, led by Medtronic at 41.0% of the total. 2025 is the largest year on record at $5,999, 3.3 times the $1,823 reported in 2019.
Across 248 payments — averaging $77.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Biotronik Inc.$7K
- Abbott$3K
- ZOLL Respicardia, Inc.$247
- Philips North America LLC$150
- Amgen$122
- plus $497 from 13 others
Across 183 payments — averaging $261.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$19K
- Biotronik Inc.$17K
- Boston Scientific$11K
What the payments were for
- Consulting fees$1501%
- Travel & lodging$12,39064%
- Food & beverage$6,69135%
- Education$700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 140 | $7,916 |
| Biotronik Inc. | 41 | $7,182 |
| Abbott | 39 | $3,188 |
| ZOLL Respicardia, Inc. | 1 | $247 |
| Philips North America LLC | 1 | $150 |
| Amgen | 1 | $122 |
| Johnson & Johnson | 5 | $110 |
| Boston Scientific | 2 | $82 |
| E.r. Squibb & Sons, L.L.C. | 4 | $70 |
| Novartis | 3 | $45 |
| Merck | 2 | $41 |
| Angiodynamics, Inc. | 1 | $32 |
| Amarin Pharma, Inc. | 2 | $30 |
| Novo Nordisk | 1 | $24 |
| Boehringer Ingelheim | 1 | $17 |
| Pfizer | 1 | $14 |
| Lexicon Pharmaceuticals, Inc. | 1 | $14 |
| Altathera Pharmaceuticals LLC | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Solia$2,159
- Selectra$1,701
- AVEIR$1,280
- EVERA MRI XT DR SURESCAN$1,109
- BioMonitor$868
- Acticor 7 VR-T DX$868
- Micra$793
- Edora 8 DR-T$458
- Rivacor 7 DR-T$458
- AMVIA EDGE$410
- remede System$247
- LINQ II$163
- Bridge$150
- QUADRA ASSURA$139
- Angio-Seal Vascular Closure Dev$129
- AZURE XT DR MRI SURESCAN$127
- Repatha$122
- Confirm Rx$121
- Reveal LINQ$118
- Azure$115
How this compares
$19,300 in reported general payments places this provider in the 55th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
See all clinical cardiac electrophysiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,067 | $1,269,788 |
| XareltoRivaroxaban | 277 | $352,920 |
| CorlanorIvabradine Hcl | 123 | $117,693 |
| EntrestoSacubitril/Valsartan | 71 | $100,249 |
| MultaqDronedarone Hcl | 35 | $57,252 |
| JardianceEmpagliflozin | 31 | $37,050 |
| Praluent PenAlirocumab | 35 | $21,299 |
| Dofetilide | 124 | $18,256 |
| Ivabradine Hcl | 33 | $17,018 |
| Midodrine Hcl | 117 | $14,423 |
| Repatha SureclickEvolocumab | 15 | $13,926 |
| Amiodarone Hcl | 385 | $12,512 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 385 | $10,693 |
| Metoprolol Succinate | 640 | $8,306 |
| Flecainide Acetate | 166 | $7,658 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $1,269,7881,067 claims |
| Johnson & JohnsonXarelto | $110 | $352,920277 claims |
| AmgenCorlanor | $122 | $117,693123 claims |
| NovartisEntresto | $45 | $100,24971 claims |
| Boehringer IngelheimJardiance | $17 | $37,05031 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
Other clinical cardiac electrophysiology in Fort Wayne
- Jason RodriguezFort Wayne$33K
- Christopher EvensonFort Wayne$29K
- J GimbelFort Wayne$25K
- Jonathan ShiraziFort Wayne$8K
- Brian CooperFort Wayne$6K
- Eric PrystowskyIndianapolis$1.1M
- Chad BonhommeWestfield$925K
- Kevin TrulockIndianapolis$402K
- Sharath VipparthyIndianapolis$114K
- Jasen GilgeIndianapolis$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.